MODIFICATION TO CMA CEREBRAL TISSUE MONITORING SYSTEM— 510(k) K071984

Substantially Equivalent

Cma Microdialysis AB

FDA 510(k) clearance K071984 for MODIFICATION TO CMA CEREBRAL TISSUE MONITORING SYSTEM, Substantially Equivalent on 2008-06-27. Applicant: Cma Microdialysis AB.

Clearance details

Applicant
Cma Microdialysis AB
Product code
Code GWM
Advisory panel
Neurology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
North Chelmsford, MA, US
Download summary PDFView on FDA.gov ↗

Adverse events under product code GWM

product code GWM
Death
21
Injury
732
Malfunction
2,063
Other
1
Total
2,817

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.